Home LiteratureArticle Details
PMID: 17116735 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Random migration precedes stable target cell interactions of tumor-infiltrating T cells.

The Journal of experimental medicine ·Vol. 203 ·No. 12 ·2006-11-27 ·Pages 2749-61

Mrass P, Takano H, Ng LG, Daxini S, Lasaro MO, Iparraguirre A, Cavanagh LL, von Andrian UH, Ertl HC, Haydon PG, Weninger W

Abstract

The tumor microenvironment is composed of an intricate mixture of tumor and host-derived cells that engage in a continuous interplay. T cells are particularly important in this context as they may recognize tumor-associated antigens and induce tumor regression. However, the precise identity of cells targeted by tumor-infiltrating T lymphocytes (TILs) as well as the kinetics and anatomy of TIL-target cell interactions within tumors are incompletely understood. Furthermore, the spatiotemporal conditions of TIL locomotion through the tumor stroma, as a prerequisite for establishing contact with target cells, have not been analyzed. These shortcomings limit the rational design of immunotherapeutic strategies that aim to overcome tumor-immune evasion. We have used two-photon microscopy to determine, in a dynamic manner, the requirements leading to tumor regression by TILs. Key observations were that TILs migrated randomly throughout the tumor microenvironment and that, in the absence of cognate antigen, they were incapable of sustaining active migration. Furthermore, TILs in regressing tumors formed long-lasting (>or=30 min), cognate antigen-dependent contacts with tumor cells. Finally, TILs physically interacted with macrophages, suggesting tumor antigen cross-presentation by these cells. Our results demonstrate that recognition of cognate antigen within tumors is a critical determinant of optimal TIL migration and target cell interactions, and argue against TIL guidance by long-range chemokine gradients.

MeSH Terms
Animals Cell Communication/immunology Cell Line, Tumor Cell Movement/immunology Cytotoxicity, Immunologic Lymphocytes, Tumor-Infiltrating/immunology,pathology Macrophages/immunology,pathology Mice Mice, Inbred C57BL Mice, Transgenic Neoplasms, Experimental/immunology,pathology T-Lymphocytes/immunology,pathology Thymoma/immunology,pathology
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Mrass Paulus
Immunology Program, The Wistar Institute, Philadelphia, PA 19104, USA.
Takano Hajime
Ng Lai Guan
Daxini Sachin
Lasaro Marcio O
Iparraguirre Amaya
Cavanagh Lois L
von Andrian Ulrich H
Ertl Hildegund C J
Haydon Philip G
Weninger Wolfgang
References (51)
51 references, click to expand
  1. Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine.
    Clin Cancer Res. 2006 Jan 1;12(1):214-22 PMID: 16397045
  2. Immune cell migration in inflammation: present and future therapeutic targets.
    Nat Immunol. 2005 Dec;6(12):1182-90 PMID: 16369557
  3. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors.
    Cancer Res. 2003 Oct 15;63(20):6838-46 PMID: 14583481
  4. Control of effector CD8+ T cell function by the transcription factor Eomesodermin.
    Science. 2003 Nov 7;302(5647):1041-3 PMID: 14605368
  5. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.
    Nature. 2004 Jan 8;427(6970):154-9 PMID: 14712275
  6. Intravital imaging of cell movement in tumours.
    Nat Rev Cancer. 2003 Dec;3(12):921-30 PMID: 14737122
  7. Bystander elimination of antigen loss variants in established tumors.
    Nat Med. 2004 Mar;10(3):294-8 PMID: 14981514
  8. The three Es of cancer immunoediting.
    Annu Rev Immunol. 2004;22:329-60 PMID: 15032581
  9. The promise of cancer vaccines.
    Nat Rev Cancer. 2004 May;4(5):401-11 PMID: 15122211
  10. Cancer immunotherapy: a treatment for the masses.
    Science. 2004 Jul 9;305(5681):200-5 PMID: 15247469
  11. Intravital microscopy: visualizing immunity in context.
    Immunity. 2004 Sep;21(3):315-29 PMID: 15357943
  12. Dynamic behavior of T cells and thymocytes in lymphoid organs as revealed by two-photon microscopy.
    Immunity. 2004 Sep;21(3):349-55 PMID: 15357946
  13. Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids.
    Cancer Res. 2004 Sep 15;64(18):6542-8 PMID: 15374966
  14. Chemoattractants and their receptors in homeostasis and inflammation.
    Curr Opin Immunol. 2004 Dec;16(6):724-31 PMID: 15511664
  15. The mechanism of T cell mediated cytotoxicity. II. Morphological studies of cell death by time-lapse microcinematography.
    Proc R Soc Lond B Biol Sci. 1976 Jan 20;192(1107):241-55 PMID: 3791
  16. Cytotoxic T lymphocyte sequential killing of immobilized allogeneic tumor target cells measured by time-lapse microcinematography.
    J Immunol. 1978 Nov;121(5):1652-6 PMID: 309477
  17. Microcinematographic and electron microscopic analysis of target cell lysis induced by cytotoxic T lymphocytes.
    Immunology. 1979 Feb;36(2):179-90 PMID: 312256
  18. A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development.
    Cell. 1994 Jun 17;77(6):917-29 PMID: 8004678
  19. Elf-1 binds to a critical element in a second CD4 enhancer.
    Mol Cell Biol. 1994 Oct;14(10):6452-63 PMID: 7935370
  20. Intravital microscopy of the peripheral lymph node microcirculation in mice.
    Microcirculation. 1996 Sep;3(3):287-300 PMID: 8930886
  21. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity.
    Nat Immunol. 2004 Dec;5(12):1235-42 PMID: 15516925
  22. The role of tumor stroma in the interaction between tumor and immune system.
    Curr Opin Immunol. 2005 Apr;17(2):180-6 PMID: 15766679
  23. CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture.
    J Immunol. 2005 May 1;174(9):5856-63 PMID: 15843590
  24. In situ characterization of CD4+ T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance.
    J Exp Med. 2005 Jun 6;201(11):1815-23 PMID: 15928201
  25. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion.
    J Exp Med. 2005 Jun 6;201(11):1805-14 PMID: 15939794
  26. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells.
    PLoS Biol. 2005 Jun;3(6):e150 PMID: 15857154
  27. Dynamic interactions of macrophages with T cells during antigen presentation.
    J Exp Med. 1999 Dec 20;190(12):1909-14 PMID: 10601366
  28. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential.
    Immunity. 2000 Sep;13(3):323-32 PMID: 11021530
  29. The immunological synapse.
    Annu Rev Immunol. 2001;19:375-96 PMID: 11244041
  30. A method that allows easy characterization of tumor-infiltrating lymphocytes.
    J Immunol Methods. 2001 Jul 1;253(1-2):163-75 PMID: 11384678
  31. Amoeboid leukocyte crawling through extracellular matrix: lessons from the Dictyostelium paradigm of cell movement.
    J Leukoc Biol. 2001 Oct;70(4):491-509 PMID: 11590185
  32. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies.
    J Pathol. 2002 Mar;196(3):254-65 PMID: 11857487
  33. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node.
    Science. 2002 Jun 7;296(5574):1869-73 PMID: 12016203
  34. Molecular anatomy of antigen-specific CD8(+) T cell engagement and synapse formation in vivo.
    Nat Immunol. 2002 Oct;3(10):918-25 PMID: 12352968
  35. Two-photon tissue imaging: seeing the immune system in a fresh light.
    Nat Rev Immunol. 2002 Nov;2(11):872-80 PMID: 12415310
  36. Targeting tumours with genetically enhanced T lymphocytes.
    Nat Rev Cancer. 2003 Jan;3(1):35-45 PMID: 12509765
  37. Understanding immune cell trafficking patterns via in vivo bioluminescence imaging.
    J Cell Biochem Suppl. 2002;39:239-48 PMID: 12552623
  38. Does the immune system see tumors as foreign or self?
    Annu Rev Immunol. 2003;21:807-39 PMID: 12615893
  39. Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy.
    Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2604-9 PMID: 12601158
  40. The use of dendritic cells in cancer immunotherapy.
    Curr Opin Immunol. 2003 Apr;15(2):138-47 PMID: 12633662
  41. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes.
    Nat Immunol. 2003 Jun;4(6):579-85 PMID: 12730692
  42. Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction.
    Cancer Cell. 2003 May;3(5):431-7 PMID: 12781360
  43. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells.
    Nature. 2003 Jul 3;424(6944):88-93 PMID: 12840763
  44. Antigen-specific immunotherapy and cancer vaccines.
    Int J Cancer. 2003 Oct 10;106(6):817-20 PMID: 12918057
  45. Adoptive-cell-transfer therapy for the treatment of patients with cancer.
    Nat Rev Cancer. 2003 Sep;3(9):666-75 PMID: 12951585
  46. Directed migration of positively selected thymocytes visualized in real time.
    PLoS Biol. 2005 Jun;3(6):e160 PMID: 15869324
  47. Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo.
    Nat Immunol. 2005 Jul;6(7):707-14 PMID: 15924144
  48. Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.
    Int J Cancer. 2005 Oct 10;116(6):949-56 PMID: 15856455
  49. An extended vision for dynamic high-resolution intravital immune imaging.
    Semin Immunol. 2005 Dec;17(6):431-41 PMID: 16216522
  50. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice.
    Nat Immunol. 2006 Jan;7(1):83-92 PMID: 16311599
  51. T cells use two directionally distinct pathways for cytokine secretion.
    Nat Immunol. 2006 Mar;7(3):247-55 PMID: 16444260
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2006-11-27
Epub
2006-00-20
Pages
2749-61
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2118164
Subset
IM
Grants
NIAID NIH HHS · R01 AI061663 · United States
NCI NIH HHS · R21 CA114114 · United States
NCRR NIH HHS · S10 RR021100 · United States
NIAID NIH HHS · AI061663 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com